Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
5,350
result(s) for
"Reprocessing"
Sort by:
Sensorimotor-focused EMDR : a new paradigm for psychotherapy and peak performance
\"Sensorimotor Focused EMDR (SF-EMDR) for Psychotherapy combines two hugely influential and effective therapies, EMDR therapy and sensorimotor psychotherapy, to provide a new approach. In doing so, the book supports the widely held view of psychotherapists that in trauma the primary store of neurological information is somatic rather than cognitive\"-- Provided by publisher.
Book
Trauma-focused therapy in early psychosis: results of a feasibility randomized controlled trial of EMDR for psychosis (EMDRp) in early intervention settings
Trauma is prevalent amongst early psychosis patients and associated with adverse outcomes. Past trials of trauma-focused therapy have focused on chronic patients with psychosis/schizophrenia and comorbid Post-Traumatic Stress Disorder (PTSD). We aimed to determine the feasibility of a large-scale randomized controlled trial (RCT) of an Eye Movement Desensitization and Reprocessing for psychosis (EMDRp) intervention for early psychosis service users.
A single-blind RCT comparing 16 sessions of EMDRp + TAU
TAU only was conducted. Participants completed baseline, 6-month and 12-month post-randomization assessments. EMDRp and trial assessments were delivered both in-person and remotely due to COVID-19 restrictions. Feasibility outcomes were recruitment and retention, therapy attendance/engagement, adherence to EMDRp treatment protocol, and the 'promise of efficacy' of EMDRp on relevant clinical outcomes.
Sixty participants (100% of the recruitment target) received TAU or EMDR + TAU. 83% completed at least one follow-up assessment, with 74% at 6-month and 70% at 12-month. 74% of EMDRp + TAU participants received at least eight therapy sessions and 97% rated therapy sessions demonstrated good treatment fidelity. At 6-month, there were signals of promise of efficacy of EMDRp + TAU
TAU for total psychotic symptoms (PANSS), subjective recovery from psychosis, PTSD symptoms, depression, anxiety, and general health status. Signals of efficacy at 12-month were less pronounced but remained robust for PTSD symptoms and general health status.
The trial feasibility criteria were fully met, and EMDRp was associated with promising signals of efficacy on a range of valuable clinical outcomes. A larger-scale, multi-center trial of EMDRp is feasible and warranted.
Journal Article
EMDR : the breakthrough therapy for overcoming anxiety, stress, and trauma
\"When EMDR was first published in 1997, it was hailed as the most important method to emerge in psychotherapy in decades. In the twenty years since, Eye Movement Desensitization and Reprocessing (EMDR) therapy has successfully treated psychological problems for millions of sufferers worldwide. In this updated edition, Francine Shapiro offers a new introduction that presents the latest applications of this remarkable therapy, as well as new scientific data demonstrating its efficacy. Drawing on the experiences of thousands of clinicians as well as a vast research literature on depression, addiction, PTSD, and other disorders, she explains how life experiences are physically stored in our brains, making us feel and act in harmful ways, and how EMDR therapy can bring relief, often in a remarkably short period of time. Applicable to survivors of trauma as well as people suffering from phobias and other experience-based disorders, EMDR is essential reading for anyone who seeks to understand why we hurt, how we heal, and how we get better.\"--Publisher's description.
Book
The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial
Previous research indicates a high prevalence of post-traumatic stress disorder (PTSD) and depression among refugees. Eye movement desensitization and reprocessing (EMDR) is an effective treatment for PTSD for victims of natural disasters, car accidents or other traumatic events. The current study examined the effect of EMDR on symptoms of PTSD and depression by comparing the treatment with a wait-list control condition in Syrian refugees.
Adult refugees located in Kilis Refugee Camp at the Turkish-Syrian border with a PTSD diagnosis were randomly allocated to either EMDR (n = 37) or wait-list control (n = 33) conditions. All participants were assessed with the Mini-International Neuropsychiatric Interview Plus at pre-intervention, at 1 week after finishing the intervention and at 5 weeks after finishing the intervention. The main outcome measures were the Harvard Trauma Questionnaire (HTQ) and the Impact of Event Scale-Revised. The Beck Depression Inventory and the Hopkins Symptoms Checklist-25 were included as secondary outcome measures. The Trial Registration no. is NCT01847742.
Mixed-model analyses adjusted for the baseline scores indicated a significant effect of group at post-treatment indicating that the EMDR therapy group showed a significantly larger reduction of PTSD symptoms as assessed with the HTQ. Similar findings were found on the other outcome measures. There was no effect of time or group × time interaction on any measure, showing that the difference between the groups at the post-treatment was maintained to the 5-week follow-up.
EMDR may be effective in reducing PTSD and depression symptoms among Syrian refugees with PTSD located in a refugee camp.
Journal Article
Microbial interaction with and tolerance of radionuclides: underlying mechanisms and biotechnological applications
Radionuclide polluted environments harbor microbial species highly tolerant to these elements through mechanisms like biosorption, biotransformation, biomineralization and intracellular accumulation. The microbial‐ radionuclide interaction processes have a great potential for biotechnological applications. This review provides the state‐ of‐ the‐ art of all aspects of these investigations. Summary Radionuclides (RNs) generated by nuclear and civil industries are released in natural ecosystems and may have a hazardous impact on human health and the environment. RN‐polluted environments harbour different microbial species that become highly tolerant of these elements through mechanisms including biosorption, biotransformation, biomineralization and intracellular accumulation. Such microbial–RN interaction processes hold biotechnological potential for the design of bioremediation strategies to deal with several contamination problems. This paper, with its multidisciplinary approach, provides a state‐of‐the‐art review of most research endeavours aimed to elucidate how microbes deal with radionuclides and how they tolerate ionizing radiations. In addition, the most recent findings related to new biotechnological applications of microbes in the bioremediation of radionuclides and in the long‐term disposal of nuclear wastes are described and discussed.
Journal Article
Study on pyrolysis suspension for treating radioactive TBP/OK spent solvents containing acidic substances
Radioactive TBP/OK spent solvents are produced by the Purex Process of the spent fuel reprocessing plant. It is a common technological route to prepare them into stable suspensions and then pyrolysis and incineration. However, when the material composition of the TBP/OK spent solvents from the previous step changes, the acidity of the waste liquid increases, resulting in the decline of the applicability of the existing suspension formulations. In this study, the effects of emulsifier type, neutralizer type, DBP content, water content, and temperature were investigated at the laboratory scale. The results show that the EO chains and PO chains in the structure of nonionic emulsifiers are beneficial to the stability of suspension, and the suspension with Mg (OH) 2 as neutralizer has better tolerance to acidity. With the increase of acid substance and DBP content from upstream Purex Process and solvent distillation, the stability of the suspension decreases, and it can be improved by increasing the amount of emulsifier. The suspension has better application in engineering when the water content is 26% - 30% and high temperature should be avoided. This study provides a reference for the adaptive adjustment of the suspension formulations at the engineering scale.
Journal Article
The effect of eye movement desensitization on neurocognitive functioning compared to retrieval-only in PTSD patients: a randomized controlled trial
Background
There is robust evidence that posttraumatic stress disorder (PTSD) is associated with neurocognitive deficits, such as executive dysfunction or memory dysfunction. Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based treatment for PTSD, in which eye movements (EMs) are performed during traumatic memory retrieval. We examined whether Eye Movement Desensitization (EMD) improves neurocognitive functioning in PTSD patients, in comparison with a retrieval-only control condition without EMs.
Methods
Adult patients with PTSD (
N
= 91) were randomized into EMD (
N
= 47) or retrieval-only (
N
= 44). Data were collected at baseline (T0), one-week post-treatment (T1), one-month follow-up (T2), and at three-month follow-up (T3). Outcome measures were the California Verbal Learning Test (CVLT), the Trail Making Test (TMT), and the Digit Span Subtest of the Wechsler Adult Intelligence Scale fourth edition (WAIS-IV). We conducted linear mixed model to analyse the main outcomes.
Results
There was a main effect of time, indicating improvements for both the EMD and retrieval-only groups in CVLT scores, TMT A, TMT B and Digit Span score of WAIS-IV (Bonferroni-adjusted
p’s
< 0.001) from T0 to T3. There were no effects of group (
p
= .64) or group by time on CVLT total trial A (T3;
p = .
34), delay A (T3;
p =
.76), TMT A (T3;
p =
.61), TMT B (T3:
p =
.58), and Digit Span scores (T3;
p =
.78) of the WAIS-IV, indicating no significant differences between groups on any of the outcomes.
Conclusion
Comparing EMD and retrieval-only did not show evidence for additive effects of EMs on the treatment of PTSD in terms of improvements in neurocognitive functioning. Thus, treatments based on retrieval of traumatic memories may be used to improve neurocognitive functioning in patients with PTSD.
Clinical trial registration
The trial was registered 19/12/2017 at ClinicalTrials.gov, identifier [ISRCTN55239132].
Journal Article